Thanks to a powerful new gene-editing technique, scientists have overcome a major hurdle for humans to receive life-saving organ transplants from pigs. In a paper in the U.S. journal Science this week, the researchers described using the ...
Tags: Gene Editing, Organ Transplant
CoreValve becomes first transcatheter heart valve approved for valve-in-valve procedures. Chris Newmarker Rendering of the CoreValve right after its transcatheter deployment. (Image courtesy of Medtronic) FDA has cleared the way for ...
Tags: FDA, Medicine, Medical Device
This year is proving to be a pretty good year for many medtech companies. The majority of the largest 40 have seen their stock prices rise by double-digit percentages in 2014, according to a Qmed analysis. Meanwhile, only eight have seen ...
Tags: Medtech Companies, Medical device
Edwards' Sapien XT transcatheter aortic heart valve (Courtesy Edwards Lifesciences) Edwards Lifesciences Corp. (Irvine, CA) has announced both the FDA approval and the U.S. launch of its next-generation Sapien XT transcatheter aortic ...
Tags: Health, Medicine, heart valve
Two new reports from iData Research cover the US market for vascular access devices and the European markets for cardiac surgery and heart valve devices. The European interventional cardiology report covers markets for tissue heart ...
Tags: Medtech Markets, US market
From a zipper-like wound closure device that can be peeled off at home to a telemedicine robot, there are plenty of ingenious devices included as finalists in this year's Medical Design Excellence Awards. It is worth noting, however, that ...
Tags: Reshaping Medtech, Health, Medicine
To develop correctly, baby hearts need rhythm...even before they have blood to pump. "We have discovered that mechanical forces are important when making baby hearts," said Mary Kathryn Sewell-Loftin, a Vanderbilt graduate student working ...
Tags: Baby Heart, Rhythm, Roadmap, SysCODE
Admedus has obtained the US Food and Drug Administration (FDA) clearance to market an advanced cardiovascular scaffold, CardioCel, which is designed to repair and treat a range of cardiovascular and vascular defects. The approval is ...
Tags: Cardiocel, FDA Clearance
Edwards Lifesciences has received regulatory approval to sell its third-generation Sapien 3 transcatheter aortic heart valve in Europe. Edwards Lifescience's Sapien 3 could be used in a broader range of patients than earlier TAVR ...
Tags: Sapien, Medtronic', CoreValve
The Gagnon Cardiovascular Institute at Morristown Medical Center became the first hospital in the tri-state area to adopt a new minimally invasive medical device to treat patients with severe aortic stenosis who are too ill or frail to ...
Medtronic willfully infringed on an Edwards Lifesciences’ patent with its CoreValve transcatheter heart valve, and owes Edwards nearly $394 million in damages and patent royalties, a federal jury in Delaware found Wednesday. Edwards ...
Tags: Medtronic, CoreValve, transcatheter heart valve, Edwards
After seeing its revenue fall over the past years, Boston Scientific is looking to boost its bottom line in China. The company is adding employees in China and is debuting surgeon-training centers there, according to a Wall Street Journal ...
Potentially harmful staph bacteria can lurk deep inside the nose, a small new study finds. Researchers tested 12 healthy people and found that formerly overlooked sites deep within the nose may be reservoirs for Staphylococcus aureus, ...
St. Jude Medical, a medical device company, has obtained CE Mark approval in Europe for its 25mm Portico transcatheter aortic heart valve implantation system. The Portico valve system offers a minimally invasive treatment option for ...
US-based SynCardia Systems has announced the implantation of the 150th SynCardia temporary total artificial heart in 2013. The 150th SynCardia temporary total artificial heart has been implanted on 26 November 2013. In 2012, a total of ...
Tags: Heart Implant, Syncardia Systems